Initial Experience of Clinical Use of [99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study

MLA

Jarosław B. Ćwikła, et al. “Initial Experience of Clinical Use of [99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study.” Pharmaceuticals, vol. 14, no. 11, Oct. 2021, p. 1107. EBSCOhost, https://doi.org/10.3390/ph14111107.

APA

Jarosław B. Ćwikła, Marek Roslan, Iwona Skoneczna, Monika Kempińska-Wróbel, Michał Maurin, Wojciech Rogowski, Barbara Janota, Anna Szarowicz, & Piotr Garnuszek. (2021). Initial Experience of Clinical Use of [99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study. Pharmaceuticals, 14(11), 1107. https://doi.org/10.3390/ph14111107

Chicago

Jarosław B. Ćwikła, Marek Roslan, Iwona Skoneczna, Monika Kempińska-Wróbel, Michał Maurin, Wojciech Rogowski, Barbara Janota, Anna Szarowicz, and Piotr Garnuszek. 2021. “Initial Experience of Clinical Use of [99mTc]Tc-PSMA-T4 in Patients with Prostate Cancer. A Pilot Study.” Pharmaceuticals 14 (11): 1107. doi:10.3390/ph14111107.